...
ABBVMEGA

AbbVie Inc.

HealthcareDrug Manufacturers - General
$232.03
$0.08(+3.27%)
52W$164.39
$244.81
FinancialsValuationvs AMGN
Updated Mar 2, 12:00 AM
RSI50
RS Rating60/99
Beta0.42
Volatility27%
F-Score6/9
Mkt Cap$410.1B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

AbbVie Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 60), indicating performance broadly in line with the market. Earnings contraction of 89% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
60
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.42
vs S&P 500
LOW VOL
52W Position
84%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$224.17
50 SMA > 100 SMA$225.68
100 SMA > 150 SMA$220.85
150 SMA > 200 SMA$212.48

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$225.67+2.82%ABOVE
50 SMA$224.17+3.51%ABOVE
100 SMA$225.68+2.82%ABOVE
150 SMA$220.85+5.06%ABOVE
200 SMA$212.48+9.20%ABOVE

Price Performance

1D+3.3%
1W+1.1%
1M+6.1%
3M+1.9%
6M+11.6%
YTD+1.2%
1Y+11.0%
3Y+14.7%
52-Week Trading Range84% from low
$232.03
52W Low$164.39
52W High$244.81

Technical Indicators

RSI (14)NEUTRAL
49.6
305070
VCP ScoreWARM
6/10
Base depth: 14.1%

Risk Profile

Beta
0.42
52W Vol
27%
ATR
$6.00
Max DD (1Y)
-21%

Volume Analysis

Today
232
50D Avg
5.67M
Vol Ratio
0.00x
Liquidity
VERY LIQUID

Earnings Momentum

Q4'24-104%
$-0.02
Q1'25-6%
$0.72
Q2'25-31%
$0.53
Q3'25-89%
$0.10
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+10.93%
5 Years:+11.11%
3 Years:+0.08%
TTM:+7.40%

Compounded Profit Growth

10 Years:+8.07%
5 Years:-14.66%
3 Years:-28.17%
TTM:-53.78%

Stock Price CAGR

10 Years:+15.57%
5 Years:+16.44%
3 Years:+14.67%
1 Year:+11.00%

Return on Equity

10Y Avg:108.3%
5Y Avg:87.6%
3Y Avg:56.5%
Last Year:62.2%

Key Metrics

Market Cap$410.1B
Gross Margin70.0%
Net Margin7.6%
Piotroski F-Score6/9

More ABBV Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

ABBV vs AMGNAMGNGILDNVOBIIB

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 60 meansABBV outperformed 60% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.42 means 58% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 6/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with WARM status.

Frequently Asked Questions

Is ABBV in an uptrend right now?

ABBV has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is ABBV overbought or oversold?

ABBV's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.

Is ABBV outperforming the market?

ABBV has a Relative Strength (RS) Rating of 60 out of 99. ABBV is performing about average compared to the market.

Where is ABBV in its 52-week range?

ABBV is trading at $232.03, which is 95% of its 52-week high ($244.81) and 84% above its 52-week low ($164.39).

How volatile is ABBV?

ABBV has a Beta of 0.42 and 52-week volatility of 27%. It's less volatile than the S&P 500 - generally more stable.